These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25849645)

  • 21. α-Synuclein in blood cells differentiates Parkinson's disease from healthy controls.
    Abd Elhadi S; Grigoletto J; Poli M; Arosio P; Arkadir D; Sharon R
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2426-2436. PubMed ID: 31742923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment.
    Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
    Mov Disord; 2010 Mar; 25(4):489-93. PubMed ID: 20063406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
    Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
    Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting Misfolded α-Synuclein in Blood Years before the Diagnosis of Parkinson's Disease.
    Kluge A; Schaeffer E; Bunk J; Sommerauer M; Röttgen S; Schulte C; Roeben B; von Thaler AK; Welzel J; Lucius R; Heinzel S; Xiang W; Eschweiler GW; Maetzler W; Suenkel U; Berg D
    Mov Disord; 2024 Aug; 39(8):1289-1299. PubMed ID: 38651526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-Synuclein as a Biomarker for Parkinson's Disease.
    Atik A; Stewart T; Zhang J
    Brain Pathol; 2016 May; 26(3):410-8. PubMed ID: 26940058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
    Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
    Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson's disease.
    Ding J; Zhang J; Wang X; Zhang L; Jiang S; Yuan Y; Li J; Zhu L; Zhang K
    J Neural Transm (Vienna); 2017 Mar; 124(3):353-360. PubMed ID: 27878377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression.
    Yang L; Stewart T; Shi M; Pottiez G; Dator R; Wu R; Aro P; Schuster RJ; Ginghina C; Pan C; Gao Y; Qian W; Zabetian CP; Hu SC; Quinn JF; Zhang J
    Proteomics Clin Appl; 2017 Jul; 11(7-8):. PubMed ID: 28319654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma alpha-synuclein levels in patients with Parkinson's disease: a systematic review and meta-analysis.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Vekrelis K; Kapaki E
    Neurol Sci; 2019 May; 40(5):929-938. PubMed ID: 30715632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower Plasma α-Synuclein Levels are Associated with Cognitive Impairment in Parkinson's Disease.
    Song Z; Shen J; Liu Y; Du X; Wu Y; Liu X; Zhang J
    Clin Lab; 2021 May; 67(5):. PubMed ID: 33978361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
    Mollenhauer B; Parnetti L; Rektorova I; Kramberger MG; Pikkarainen M; Schulz-Schaeffer WJ; Aarsland D; Svenningsson P; Farotti L; Verbeek MM; Schlossmacher MG
    J Neurochem; 2016 Oct; 139 Suppl 1():290-317. PubMed ID: 26452984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.
    Chung CC; Chan L; Chen JH; Hung YC; Hong CT
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.
    Shi M; Zabetian CP; Hancock AM; Ginghina C; Hong Z; Yearout D; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Leverenz JB; Zhang J
    Neurosci Lett; 2010 Aug; 480(1):78-82. PubMed ID: 20540987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease.
    Waragai M; Sekiyama K; Sekigawa A; Takamatsu Y; Fujita M; Hashimoto M
    Int J Mol Sci; 2010 Oct; 11(11):4257-66. PubMed ID: 21151436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles.
    Yang SY; Chiu MJ; Lin CH; Horng HE; Yang CC; Chieh JJ; Chen HH; Liu BH
    J Nanobiotechnology; 2016 Jun; 14(1):41. PubMed ID: 27278241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.
    Eidson LN; Kannarkat GT; Barnum CJ; Chang J; Chung J; Caspell-Garcia C; Taylor P; Mollenhauer B; Schlossmacher MG; Ereshefsky L; Yen M; Kopil C; Frasier M; Marek K; Hertzberg VS; Tansey MG
    J Neuroinflammation; 2017 Aug; 14(1):164. PubMed ID: 28821274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson's Disease.
    Abd-Elhadi S; Honig A; Simhi-Haham D; Schechter M; Linetsky E; Ben-Hur T; Sharon R
    Sci Rep; 2015 Jun; 5():11120. PubMed ID: 26068055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis.
    Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
    BMJ Open; 2016 Jun; 6(6):e011113. PubMed ID: 27297011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
    Delgado-Alvarado M; Gago B; Gorostidi A; Jiménez-Urbieta H; Dacosta-Aguayo R; Navalpotro-Gómez I; Ruiz-Martínez J; Bergareche A; Martí-Massó JF; Martínez-Lage P; Izagirre A; Rodríguez-Oroz MC
    Mov Disord; 2017 Jul; 32(7):1066-1073. PubMed ID: 28548309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.